Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Protagenic Therapeutics (PTIX) has issued an announcement.
In a positive turn for investors, a company has successfully addressed its previous Nasdaq non-compliance issue by maintaining its stock price above the $1.00 minimum bid price for ten consecutive trading days. This accomplishment has resulted in the Nasdaq Listing Qualifications Department closing the deficiency notice, ensuring the company’s continued listing on the exchange and potentially restoring investor confidence in its financial stability.
For detailed information about PTIX stock, go to TipRanks’ Stock Analysis page.